T&R Biofab Co., Ltd.
Research T&R Biofab Co., Ltd. (246710.KQ) on Bullrun: market cap KRW 96.56B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker246710.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 96.56B
- Financial periodQ2 2026
- RevenueKRW 9.54B
- Net income-KRW 3.78B
- Free cash flow-KRW 1.91B
- Gross margin33.4%
Valuation Snapshot
latest market cap is KRW 96.56B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 96.56B | n/a | n/a | n/a |
Dividend history
About T&R Biofab Co., Ltd.
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is T&R Biofab Co., Ltd.'s market cap?
T&R Biofab Co., Ltd.'s market capitalization is KRW 96.56B.
What does T&R Biofab Co., Ltd. do?
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.